Hips Screws or (Total) Hip Replacement for Undisplaced Femoral Neck Fractures in Elderly Patients (HipSTHeR)
Launched by UPPSALA UNIVERSITY · May 24, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The HipSTHeR trial is studying the best way to treat a specific type of hip fracture, known as an undisplaced femoral neck fracture, in older patients. This trial will compare two treatment options: using screws to hold the bone together (called internal fixation) versus replacing the hip joint with an artificial one (called arthroplasty). The goal is to see if hip replacement can help reduce the number of patients who need additional surgeries later on.
To participate in this trial, patients need to have an undisplaced femoral neck fracture that occurred within the last 72 hours. They must be treated at one of the hospitals involved in the study and give their consent to join. The trial is open to all adults, regardless of gender, and is currently looking for volunteers. Participants can expect close monitoring and care throughout the study, and their involvement will help researchers find the best treatment for this type of injury in older adults.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Undisplaced (Garden I-II) femoral neck fracture (within 72h)
- • treated at participating unit
- • informed consent
- • amenable for both treatment options
- Exclusion Criteria:
- • no informed consent
- • pathological or stress fracture
- • peri-implant fracture
About Uppsala University
Uppsala University, a prestigious institution located in Sweden, is renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive expertise in various fields of health sciences to conduct innovative studies aimed at improving patient outcomes and understanding complex diseases. With a strong emphasis on ethical standards and rigorous scientific methodologies, Uppsala University collaborates with a network of researchers, healthcare professionals, and industry partners to facilitate groundbreaking clinical trials that contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gothenburg, , Sweden
Stockholm, , Sweden
Luleå, , Sweden
Linköping, , Sweden
Västerås, , Sweden
Umeå, , Sweden
Kalmar, , Sweden
Alingsås, , Sweden
Falun, , Sweden
Skellefteå, , Sweden
Borås, , Sweden
Karlskrona, , Sweden
Västervik, , Sweden
Kungälv, , Sweden
Stockholm, , Sweden
Gävle, , Sweden
Skövde, , Sweden
Nyköping, , Sweden
Jönköping, , Sweden
Mora, , Sweden
Lycksele, , Sweden
Uppsala, Uppsala Lan, Sweden
Malmö, , Sweden
Norrtälje, , Sweden
Trollhättan, , Sweden
Patients applied
Trial Officials
Stergios Lazarinis
Study Chair
Uppsala University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials